Total Synthesis of Thiaplakortone A: Derivatives as Metabolically Stable Leads for the Treatment of Malaria

Thiaplakortone A (3a), an antimalarial natural product, was prepared by an operationally simple and scalable synthesis. In our efforts to deliver a lead compound with improved potency, metabolic stability, and selectivity, the synthesis was diverted to access a series of analogues. Compounds 3a–d sh...

Full description

Saved in:
Bibliographic Details
Published inACS medicinal chemistry letters Vol. 5; no. 2; pp. 178 - 182
Main Authors Pouwer, Rebecca H, Deydier, Sophie M, Le, Phuc Van, Schwartz, Brett D, Franken, Nicole C, Davis, Rohan A, Coster, Mark J, Charman, Susan A, Edstein, Michael D, Skinner-Adams, Tina S, Andrews, Katherine T, Jenkins, Ian D, Quinn, Ronald J
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 13.02.2014
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Thiaplakortone A (3a), an antimalarial natural product, was prepared by an operationally simple and scalable synthesis. In our efforts to deliver a lead compound with improved potency, metabolic stability, and selectivity, the synthesis was diverted to access a series of analogues. Compounds 3a–d showed nanomolar activity against the chloroquine-sensitive (3D7) Plasmodium falciparum line and were more active against the chloroquine- and mefloquine-resistant (Dd2) P. falciparum line. All compounds are “Rule-of-5” compliant, and we show that metabolic stability can be enhanced via modification at either the primary or pyrrole nitrogen. These promising results lay the foundation for the development of this structurally unprecedented natural product.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1948-5875
1948-5875
DOI:10.1021/ml400447v